Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

[Summary] 研发新药,改善人类健康

上海恒瑞研发中心始建于2004年5月,位于文井路279号,总投资2亿元,占地面积44000平方米,建筑面积26409.6平方米,其中生产试验车间10005.6平方米,研发中心10053.53平方米。是江苏恒瑞医药有限公司的主要研发基地之一。
上海研发中心致力于创新药物的发现,以抗肿瘤、内分泌、心血管、中枢神经、大分子生物为重点的创新方向,涵盖新药开发全过程。

目前承担了多项国家“重大新药创制”科技重大专项项目。已提交了国家专利申请46项,PCT申请33项,并开始进入包括美国、欧洲、日本等16个国家。4项创新一类药已拿到国家I期临床批件。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (16 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 12%
  • 2024: Up 39%
  • 2023: Up 14%
  • 2022: Down 77%
Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Campus Recruitment & Advanced Degree Talent Demand
Master's 2 Doctorate 2
Note: How fast is hiring at 上海恒瑞医药有限公司 growing? 2025年155个(增长12%),2024年138个(增长39%),2023年99个(增长14%),2022年87个(下降77%),2021年376个. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Up 39%
  • 2023: Down 16%
  • 2022: Down 55%
Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 上海恒瑞医药有限公司 growing? 历年硕士招聘职位量:2025年53个(持平),2024年53个(增长39%),2023年38个(下降16%),2022年45个(下降55%),2021年101个.

Doctoral Degree Job Demand Analysis

(More)
-79%
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Down 30%
  • 2023: Up 67%
  • 2022: Down 71%
Doctoral Hiring by Year: 2026 — 11 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 上海恒瑞医药有限公司 growing? 历年博士招聘职位量:2026年3个(下降79%),2025年14个(持平),2024年14个(下降30%),2023年20个(增长67%),2022年12个(下降71%),2021年42个. 上海恒瑞医药有限公司在上海博士人才需求中排名第161, 上海恒瑞医药有限公司博士工资大部分在20-50K.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 上海恒瑞医药有限公司? Based on an analysis of 's job postings over the past year, “医疗卫生/美容保健类”需求占38.5%,“生物/制药/化工/环保类”占33.3%,“科研类”占26.9%,“其他(研发和技术类)”占23.1%,“计算机/网络/技术类”占9%,“农林渔类”占3.8%. For reference only.

— What Are the Salaries Like? (78 records)

Manage
salary range: 8K - 50K, 78.2% of roles pay ¥15-50K
Note: salary statistics are based on 78 salary records from the past year and depend on the job sample. For reference only.
上海恒瑞医药有限公司工资待遇怎么样?78.2%的岗位拿15-50K,本科工资¥。与同行业比+27%,医疗卫生/美容保健类平均工资¥26.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at 上海恒瑞医药有限公司? We provide: 研究员,信息,临床,医药代表,写作,协调专员,运营,抗体发现,分析,生产工,项目负责人,pm,ra,td,地区经理,精益主管,转化医学,销售,qc,市场. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Job Category

  • 医疗卫生/美容保健类
    37.5% of total 37.5%
  • 销售类
    36.3% of total 36.3%
  • 生物/制药/化工/环保类
    32.5% of total 32.5%
  • 科研类
    26.3% of total 26.3%

Education

  • 本科
    53.8% of total 53.8%
  • 硕士
    30% of total 30%
  • 博士
    11.3% of total 11.3%
  • 大专
    5% of total 5%

Experience

  • 不限
    48.8% of total 48.8%
  • 3-5年
    26.3% of total 26.3%
  • 1-3年
    21.3% of total 21.3%
  • 5-10年
    3.8% of total 3.8%
View Detailed Analysis

What does 上海恒瑞医药有限公司 require? Who is 上海恒瑞医药有限公司 hiring? 招聘类别医疗卫生/美容保健类占比最多占37.5%,其次是销售类占36.3%。什么学历能进?本科占比最多占53.8%,其次是硕士占30%。学历要求高吗?硕士占30%,博士占11.3%。工作经验有什么要求?不限占比最多占48.8%,其次是3-5年占26.3%。工作地区在哪?上海占比最多占68.8%,其次是北京占5%。 Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 7,200万(元)
Legal Representative: 卢韵
Date Established:
Credit Code: 9131000073336184XW
Registered Address: 上海市闵行区经济技术开发区文井路279号

Partners & Suppliers

2021年,恒瑞医药与璎黎药业达成合作,获得PI3Kδ抑制剂YY-20394在大中华区的独家权益,璎黎药业为技术授权方。 Source
供应商 产品授权/战略合作
泰格医药为恒瑞医药提供临床试验设计、数据管理等临床CRO服务。 Source
供应商 CRO/临床服务
九州通与恒瑞医药在基层医疗市场合作,负责部分药品的配送。 Source
合作客户 医药商业
华润医药是恒瑞医药的药品分销合作伙伴,覆盖华北及全国重点医院。 Source
合作客户 医药商业
康龙化成为恒瑞医药提供药物发现、药代动力学等CRO服务。 Source
供应商 CRO/临床服务

People who follow this company also follow

Competitors (Similar Companies)

“抗肿瘤药和手术用药的研究和生产”
“不断创新为患者带来能显着改善其健康的药物”
“球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台公司”
“专注于医药健康、生命科学和电子科技三大领域”
“在快速成长的生物制药领域,加快和转变制药发现、开发及生产,以造福全球患者”
“促进人类健康”
制药/药业 制药 抗肿瘤药 肿瘤检测
“合成生物学、生物材料研究及生物制造产业化”
“中国肝病、抗肿瘤领域的知名企业”
“改善人们的生活质量”
“开发老百姓都用得着、用得起的高质量的生物药”
“致力于分子靶向药物和免疫肿瘤药物研发,及商业创新领域”
“关爱生命、嗬护健康”
“关爱全世界,关注每个人”
“帮助伙伴们成功开发新药,降低新药研发成本,提高新药研发效率”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates

家政服务
客服
由百度提供